Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures
NCT ID: NCT02368730
Last Updated: 2017-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
23 participants
OBSERVATIONAL
2015-06-30
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Desmopressin for Bleeding Related to Low Body Temperature
NCT00902057
Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept
NCT00961532
Impact of Intranasal Insulin on Sympathetic Activity and Cerebral Vasodilation
NCT05153395
the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal Shock
NCT04586790
Normothermia in Patients With Acute Cerebral Damage
NCT00491192
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
desmopressin
Treatment according to standard clinical practice.
desmopressin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
desmopressin
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Decision on the therapy with MINIRIN parenteral 4 Microgram/ml solution for injection has already been made independently by the physician beforehand
* The patients (≥ 18 years) have been informed about the non-interventional study and have given their written consent for participation
Exclusion Criteria
* Treatment with acetylsalicylic acid for cardiovascular indications
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ferring Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Development Support
Role: STUDY_DIRECTOR
Ferring Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charité - Universitätsmedizin Berlin (there may be other sites in this country)
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
000149
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.